Home Management of Patients with Moderate or Severe Respiratory Failure Secondary to COVID-19, Using Remote Monitoring and Oxygen with or without HFNC
Background: Home treatment of patients affected by COVID-19 is still a matter of daily debate. During the clinical evolution of the disease, there are high risks of lung failure, which requires oxygen therapy. Here, we report our clinical experience with at-home treatment using high-flow nasal cannu...
Main Authors: | Anna Annunziata, Antonietta Coppola, Novella Carannante, Francesca Simioli, Maurizia Lanza, Pierpaolo Di Micco, Giuseppe Fiorentino |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/4/413 |
Similar Items
-
The importance of high flow nasal cannula (HFNC) oxygen therapy
by: TIGLIS Mirela, et al.
Published: (2019-03-01) -
Comparison of CPAP and HFNC in Management of Bronchiolitis in Infants and Young Children
by: Majken Bisgaard Pedersen, et al.
Published: (2017-04-01) -
The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China
by: Ke Wang, et al.
Published: (2020-03-01) -
Clinical studies with high flow nasal cannula oxygen delivery in 2015
by: David Sotello, et al.
Published: (2016-04-01) -
Evaluation of the therapeutic effect of high-flow nasal cannula oxygen therapy on patients with aspiration pneumonia accompanied by respiratory failure in the post-stroke sequelae stage
by: Dong Xing, et al.
Published: (2021-01-01)